28357214|t|Angiotensin II type 1 receptor blockers increase tolerance of cells to copper and cisplatin.
28357214|a|The human pathology Wilson disease (WD) is characterized by toxic copper (Cu) accumulation in brain and liver, resulting in, among other indications, mitochondrial dysfunction and apoptosis of hepatocytes. In an effort to identify novel compounds that can alleviate Cu-induced toxicity, we screened the Pharmakon 1600 repositioning library using a Cu-toxicity yeast screen. We identified 2 members of the drug class of Angiotensin II Type 1 receptor blockers (ARBs) that could increase yeast tolerance to Cu, namely Candesartan and Losartan. Subsequently, we show that specific ARBs can increase yeast tolerance to Cu and/or the chemotherapeutic agent cisplatin (Cp). The latter also induces mitochondrial dysfunction and apoptosis in mammalian cells. We further demonstrate that specific ARBs can prevent the prevalence of Cu-induced apoptotic markers in yeast, with Candesartan Cilexetil being the ARB which demonstrated most pronounced reduction of apoptosis-related markers. Next, we tested the sensitivity of a selection of yeast knockout mutants affected in detoxification of reactive oxygen species (ROS) and Cu for Candesartan Cilexetil rescue in presence of Cu. These data indicate that Candesartan Cilexetil increases yeast tolerance to Cu irrespectively of major ROS-detoxifying proteins. Finally, we show that specific ARBs can increase mammalian cell tolerance to Cu, as well as decrease the prevalence of Cu-induced apoptotic markers. All the above point to the potential of ARBs in preventing Cu-induced toxicity in yeast and mammalian cells.
28357214	0	39	Angiotensin II type 1 receptor blockers	Gene	
28357214	71	77	copper	Chemical	MESH:D003300
28357214	82	91	cisplatin	Chemical	MESH:D002945
28357214	97	102	human	Species	9606
28357214	113	127	Wilson disease	Disease	MESH:D006527
28357214	129	131	WD	Disease	MESH:D006527
28357214	159	165	copper	Chemical	MESH:D003300
28357214	167	169	Cu	Chemical	MESH:D003300
28357214	243	268	mitochondrial dysfunction	Disease	MESH:D028361
28357214	359	361	Cu	Chemical	MESH:D003300
28357214	370	378	toxicity	Disease	MESH:D064420
28357214	441	443	Cu	Disease	
28357214	444	452	toxicity	Disease	MESH:D064420
28357214	453	458	yeast	Species	4932
28357214	512	551	Angiotensin II Type 1 receptor blockers	Gene	
28357214	553	557	ARBs	Gene	
28357214	579	584	yeast	Species	4932
28357214	598	600	Cu	Chemical	MESH:D003300
28357214	609	620	Candesartan	Chemical	MESH:C081643
28357214	625	633	Losartan	Chemical	MESH:D019808
28357214	689	694	yeast	Species	4932
28357214	708	710	Cu	Chemical	MESH:D003300
28357214	745	754	cisplatin	Chemical	MESH:D002945
28357214	785	810	mitochondrial dysfunction	Disease	MESH:D028361
28357214	828	837	mammalian	Species	9606
28357214	917	919	Cu	Chemical	MESH:D003300
28357214	949	954	yeast	Species	4932
28357214	961	982	Candesartan Cilexetil	Chemical	MESH:C077793
28357214	1122	1127	yeast	Species	4932
28357214	1175	1198	reactive oxygen species	Chemical	MESH:D017382
28357214	1200	1203	ROS	Chemical	MESH:D017382
28357214	1209	1211	Cu	Chemical	MESH:D003300
28357214	1216	1237	Candesartan Cilexetil	Chemical	MESH:C077793
28357214	1260	1262	Cu	Chemical	MESH:D003300
28357214	1289	1310	Candesartan Cilexetil	Chemical	MESH:C077793
28357214	1321	1326	yeast	Species	4932
28357214	1340	1342	Cu	Chemical	MESH:D003300
28357214	1367	1370	ROS	Chemical	MESH:D017382
28357214	1424	1428	ARBs	Gene	
28357214	1442	1451	mammalian	Species	9606
28357214	1470	1472	Cu	Chemical	MESH:D003300
28357214	1512	1514	Cu	Chemical	MESH:D003300
28357214	1582	1586	ARBs	Gene	
28357214	1601	1603	Cu	Chemical	MESH:D003300
28357214	1612	1620	toxicity	Disease	MESH:D064420
28357214	1624	1629	yeast	Species	4932
28357214	1634	1643	mammalian	Species	9606
28357214	Positive_Correlation	MESH:D003300	MESH:D006527
28357214	Association	MESH:C077793	MESH:D003300
28357214	Positive_Correlation	MESH:D003300	MESH:D028361

